Tandem Diabetes Care, Inc. ( TNDM) - Key Metrics
TNDM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $3.72 | -$0.31 | -$0.51 | -$0.57 |
| 2026Q1 | $3.61 | -$0.30 | $0.16 | $0.07 |
| 2025Q4 | $4.27 | -$0.01 | $0.14 | $0.05 |
| 2025Q3 | $3.68 | -$0.31 | $0.12 | $0.06 |
| 2025Q2 | $3.59 | -$0.78 | -$0.14 | -$0.23 |
TNDM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -12.17 |
| 2026Q1 | 0% | -15.98 |
| 2025Q4 | 0% | -631.61 |
| 2025Q3 | 0% | -9.79 |
| 2025Q2 | 0% | -5.97 |
TNDM
Price: $22.72
52 week price:
Earnings Per Share: -0.92 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 448000
Ebitda: -11.4 millionMarket Capitalization: 1.6 billion